Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - UDG Healthcare plc

16th Jun 2021 07:00

RNS Number : 0707C
Societe Generale SA
16 June 2021
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Société Générale S.A.

Company dealt in

UDG Healthcare plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

€0.05 ordinary shares

Date of dealing

15/06/2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

10,277,446

4.08

4,867

0.00

(2) Derivatives (other than options)

0

0.00

6,188,855

2.46

(3) Options and agreements to purchase/sell

0

0.00

0

0.00

Total

*10,337,446

*4.10

6,193,722

2.46

* Include the holding of 60,000 shares on borrow products

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit GBP (Note 5)

Purchase

413

10.44

Purchase

207

10.43

Purchase

414

10.42

Purchase

58

10.43

Purchase

414

10.43

Purchase

250

10.44

Purchase

320

10.44

Purchase

468

10.44

Purchase

444

10.45

Purchase

8

10.43

Purchase

310

10.43

Purchase

288

10.44

Purchase

290

10.44

Purchase

270

10.43

Purchase

288

10.43

Purchase

340

10.44

Purchase

377

10.43

Purchase

325

10.43

Purchase

328

10.44

Purchase

829

10.45

Purchase

322

10.43

Purchase

337

10.44

Purchase

307

10.43

Purchase

184

10.43

Purchase

126

10.43

Purchase

310

10.44

Purchase

336

10.43

Purchase

33

10.43

Purchase

288

10.43

Purchase

178

10.44

Purchase

307

10.43

Purchase

330

10.42

Purchase

235

10.43

Purchase

213

10.43

Purchase

36

10.43

Purchase

333

10.44

Purchase

210

10.43

Purchase

325

10.43

Purchase

176

10.43

Purchase

144

10.44

Purchase

312

10.43

Purchase

164

10.44

Purchase

301

10.43

Purchase

316

10.43

Purchase

322

10.42

Purchase

340

10.42

Purchase

423

10.43

Purchase

829

10.43

Purchase

233

10.43

Purchase

710

10.43

Purchase

240

10.43

Purchase

351

10.43

Purchase

830

10.43

Purchase

337

10.42

Purchase

214

10.44

Purchase

256

10.44

Purchase

330

10.43

Purchase

326

10.43

Purchase

271

10.43

Purchase

829

10.43

Purchase

830

10.43

Purchase

239

10.44

Purchase

328

10.43

Purchase

237

10.43

Purchase

327

10.41

Purchase

312

10.44

Purchase

305

10.44

Purchase

304

10.43

Purchase

450

10.43

Purchase

241

10.43

Purchase

336

10.44

Purchase

304

10.43

Purchase

315

10.44

Purchase

54

10.43

Purchase

12,000

10.454585

Purchase

24,000

10.454585

Sale

250

10.42

Sale

563

10.42

Sale

726

10.42

Sale

346

10.43

Sale

73

10.43

Sale

22

10.43

Sale

250

10.43

Sale

56

10.43

Sale

55

10.43

Sale

66

10.43

Sale

918

10.47

Sale

207

10.44

Sale

999

10.43

Sale

204

10.43

Sale

256

10.44

Sale

449

10.42

Sale

3

10.43

Sale

3

10.43

Sale

15

10.44

Sale

296

10.44

Sale

3

10.43

Sale

3

10.43

Sale

221

10.43

Sale

148

10.43

Sale

36

10.43

Sale

4

10.43

Sale

3

10.43

Sale

3

10.43

Sale

3

10.43

Sale

3

10.43

Sale

392

10.43

Sale

356

10.43

Sale

11

10.44

Sale

66

10.44

Sale

309

10.44

Sale

60

10.43

Sale

146

10.43

Sale

15

10.43

Sale

504

10.43

Sale

19

10.43

Sale

79

10.43

Sale

91

10.43

Sale

22

10.43

Sale

634

10.43

Sale

32

10.43

Sale

241

10.43

Sale

156

10.42

Sale

340

10.42

Sale

357

10.42

Sale

837

10.43

Sale

401

10.43

Sale

305

10.43

Sale

14

10.44

Sale

294

10.44

Sale

1,712

10.44

Sale

3,501

10.44

Sale

264

10.44

Sale

833

10.44

Sale

1,394

10.42

Sale

263

10.44

Sale

441

10.43

Sale

231

10.43

Sale

324

10.43

Sale

112

10.42

Sale

334

10.42

Sale

110

10.44

Sale

691

10.44

Sale

305

10.44

Sale

500

10.43

Sale

25

10.43

Sale

459

10.43

Sale

636

10.43

Sale

131

10.43

Sale

324

10.42

Sale

13

10.42

Sale

400

10.43

Sale

362

10.43

Sale

775

10.43

Sale

1,169

10.44

Sale

187

10.41

Sale

140

10.41

Sale

340

10.43

Sale

15

10.43

Sale

26

10.43

Sale

321

10.43

Sale

22

10.43

Sale

13

10.44

Sale

294

10.44

Sale

372

10.43

Total Purchases

59,887

 

Total Sales

28,904

 

 

Derivatives transactions (other than options transactions)

 

Product name,e.g. CFD

Nature of transaction(Note 6)

Number of relevant securities(Note 7)

Price per unit GBP(Note 5)

CFD

Increased short

12,000

10.454585

CFD

Increased short

24,000

10.454585

 

(b) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(c) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

 

Agreements, arrangements, or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  No

 

Date of disclosure

16/06/2021

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEEASKKFSNFEEA

Related Shares:

UDG.L
FTSE 100 Latest
Value9,120.31
Change-18.06